Sage Therapeutics to Present at the Stifel 2023 CNS Days
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 22, 2023--
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Stifel 2023 CNS Days on Wednesday, March 29, 2023, at 11:00 a.m. ET.
A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20230321005679/en/
CONTACT: Investor Contact
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.comMedia Contact
Matthew Henson
917-930-7147
matthew.henson@sagerx.com
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH NEUROLOGY RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY
SOURCE: Sage Therapeutics, Inc.
Copyright Business Wire 2023.
PUB: 03/22/2023 06:30 AM/DISC: 03/22/2023 06:30 AM
http://www.businesswire.com/news/home/20230321005679/en
